Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 201.60
-5.00 (-2.42%)
Jun 1, 2026, 3:29 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 13.54 billion as of June 1, 2026. Its market cap has decreased by -8.29% in one year.
Market Cap
13.54B
Enterprise Value
12.56B
Revenue
2.87B
Ranking
n/a
PE Ratio
31.95
Stock Price
201.60
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 13.54B, a decrease of -23.23%. That is a compound annual growth rate of -1.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 13.54B | 5.23% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 48.66B |
| Orchid Pharma | 40.19B |
| RPG Life Sciences | 36.79B |
| Solara Active Pharma Sciences | 25.66B |
| Indoco Remedies | 19.35B |
| Sakar Healthcare | 17.72B |
| Windlas Biotech | 17.58B |
| Beta Drugs | 14.43B |